États-Unis · Magazines éco · Quartz

Pfizer is tapping Blackstone for up to $1.5 billion to fund its weight-loss drug

Publié par Quartz · États-Unis il y a 32 min

Pfizer is tapping Blackstone for up to $1.5 billion to fund its weight-loss drug — Quartz

Résumé détaillé

Blackstone would be eligible for milestone payments tied to U.S. approval of monthly berobenatide, while Pfizer keeps full control

Lire l'article complet sur Quartz Connectez-vous pour sauvegarder

MarketNews présente le titre et le résumé publiés par le média. L'article complet se lit sur le site de l'éditeur. (qz.com)

À lire aussi

The cracks in venture are beginning to show, just as Anthropic gets ready to IPO

How to Protect an Aging Parent’s Finances Without Conflict

After 28 Years, Apple Is Shutting Down Its Most Valuable Customer Support Tool

The best AI lab in business is not for sale—you already own it

Markets Insider (Business Insider)

DarioHealth GAAP EPS of $0.73 beats by $1.68, revenue of $5.31M beats by $0.1M

In Healthcare, Legacy And Values Are The Foundation For Innovation And Growth